In this study we aimed to investigate the combinatory effects of human glutaminyl cyclase activity (pyroglutamylation) and metabolic dysfunction in AD pathology by inducing T2D in the pGlu-Aβ-expressing APPxhQC mouse model. Here, QPCT is linked to type 2 diabetes mellitus.